These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 33069869

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Median nerve stimulation induces analgesia via orexin-initiated endocannabinoid disinhibition in the periaqueductal gray.
    Chen YH, Lee HJ, Lee MT, Wu YT, Lee YH, Hwang LL, Hung MS, Zimmer A, Mackie K, Chiou LC.
    Proc Natl Acad Sci U S A; 2018 Nov 06; 115(45):E10720-E10729. PubMed ID: 30348772
    [Abstract] [Full Text] [Related]

  • 3. Stress induces analgesia via orexin 1 receptor-initiated endocannabinoid/CB1 signaling in the mouse periaqueductal gray.
    Lee HJ, Chang LY, Ho YC, Teng SF, Hwang LL, Mackie K, Chiou LC.
    Neuropharmacology; 2016 Jun 06; 105():577-586. PubMed ID: 26907809
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The inhibition of the nitric oxide-cGMP-PKG-JNK signaling pathway avoids the development of tolerance to the local antiallodynic effects produced by morphine during neuropathic pain.
    Hervera A, Leánez S, Pol O.
    Eur J Pharmacol; 2012 Jun 15; 685(1-3):42-51. PubMed ID: 22546233
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The Selective Monoacylglycerol Lipase Inhibitor MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model.
    Wilkerson JL, Niphakis MJ, Grim TW, Mustafa MA, Abdullah RA, Poklis JL, Dewey WL, Akbarali H, Banks ML, Wise LE, Cravatt BF, Lichtman AH.
    J Pharmacol Exp Ther; 2016 Apr 15; 357(1):145-56. PubMed ID: 26791602
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Slowly Signaling G Protein-Biased CB2 Cannabinoid Receptor Agonist LY2828360 Suppresses Neuropathic Pain with Sustained Efficacy and Attenuates Morphine Tolerance and Dependence.
    Lin X, Dhopeshwarkar AS, Huibregtse M, Mackie K, Hohmann AG.
    Mol Pharmacol; 2018 Feb 15; 93(2):49-62. PubMed ID: 29192123
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Disability of development of tolerance to morphine and U-50,488H, a selective kappa-opioid receptor agonist, in neuropathic pain model mice.
    Sounvoravong S, Takahashi M, Nakashima MN, Nakashima K.
    J Pharmacol Sci; 2004 Mar 15; 94(3):305-12. PubMed ID: 15037816
    [Abstract] [Full Text] [Related]

  • 18. Involvement of cannabinoid (CB1)-receptors in the development and maintenance of opioid tolerance.
    Trang T, Sutak M, Jhamandas K.
    Neuroscience; 2007 May 25; 146(3):1275-88. PubMed ID: 17395382
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.